Biologics: Do They Prevent Joint Damage and Deformity?

When Enbrel (etanercept), the first biologic therapy for rheumatoid arthritis became available in 1998, it was said that it could slow disease progression. Other biologics followed including: Remicade (infliximab), Humira (adalimumab), Rituxan (rituximab), and Orencia (abatacept).

• Has it been proven that these drugs prevent joint damage and deformity?
• Will a person with early rheumatoid arthritis who starts on a biologic drug not experience joint deformities?

We asked rheumatologist Scott J. Zashin, M.D. to explain, Do Biologics Prevent Joint Damage and Deformity?

Related Resources:

• Arthritis Hand Photo Gallery
• Biologic Response Modifier: What is it?
• Rheumatoid Arthritis Hand Deformity: Is it Inevitable?
• Are Some Arthritis Patients Unsuitable Candidates for Biologic Drugs?
• Is Early, Aggressive Treatment Recommended for Rheumatoid Arthritis?

Join the Discussion:

• Join Us in Our Arthritis Forum

_{Photo © About.com}